Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Champix approved in Europe

Oct. 2, 2006

PharmAthene awarded Department of Defense contract for Protexia development

Sep. 27, 2006

ArmaGen receives grant to develop first nerve gas antidote

Sep. 20, 2006

SBIR grant for Cleveland BioLabs' radioprotector research

Sep. 12, 2006

Aktiv-Dry awarded grant to develop inhalable nicotine vaccine

Sep. 4, 2006

E.U. approval for Exjade

Aug. 30, 2006

Antidote for isotope intoxication reported by Department of Atomic Energy in India

Aug. 8, 2006

Chantix now available in U.S.

Aug. 2, 2006

Protectan CBLB-502 demonstrates effectiveness in ARS in primates

Aug. 2, 2006

Champix recommended for approval in Europe

July 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...